Henan Taloph Pharmaceutical Stock Co. Ltd. Class ASSE: 600222

Announcement on Stock Suspension Due to Controlling Shareholder's Planning of Major Matters

· Issued by Henan Taloph Pharmaceutical Stock Co. Ltd. Class A via Shanghai Stock Exchange
(600222“Henan Taloph Pharmaceutical Stock Co., Ltd.”Announcement on Stock Suspension Due to Controlling Shareholder's Planning of Major Matters)

As the Controlling Shareholder of Henan Taloph Pharmaceutical Stock Co., Ltd., Zhengzhou Tairong Industrial Investment Co., Ltd., is currently planning a share transfer that may lead to a change in the company's control, and in accordance with relevant regulations, the company has applied to the Shanghai Stock Exchange. The company's shares will be suspended from trading at the market open on December 2, 2025, with the expected suspension period not exceeding two trading days.

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment